Clinical trials: Observational

Observational

Real-World Treatment Study of Soliris (Eculizumab)

• Completed
• Age: All ages
• Observational study

As part of a post-approval commitment, the Korean health authority requests a study to characterize safety and effectiveness in patients who are treated with Soliris in normal clinical practice settings.

Trial name

SolirisPMS (NCT06448715)

Where

2 sites in South Korea

Volunteers

11 people

Sponsor

AstraZeneca